Deepti Formulations Private Limited
About Deepti Formulations Private Limited
Data last updated:
Deepti Formulations Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 24 December 1990 and has been in existence for over 36 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24231TG1990PTC012122. Its GSTIN is 36AAACD7145G1ZS (Telangana). The company holds 2 GST registrations, of which 1 is active.
The company has an authorised share capital of ₹20 Lakh and a paid-up capital of ₹11.5 Lakh. It is led by directors including Ashwini Chadda (Whole-Time Director) and Dhruv Chadda.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at M – 7/2 Street No.1 (Near Kakatiya Club) Kakatiyanagar Habshiguda, Hyderabad, Telangana, India – 500007.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.03 Cr, a decline of 72% compared to the previous year. For the same year it recorded a net loss of ₹72.99 Lakh (net margin -18.1%) and EBITDA of -₹32.52 Lakh (EBITDA margin -8.1%). Revenue has declined at a compounded annual rate (CAGR) of 22% over three years and 16% over five years.
The company has about 36 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹82.6 Lakh and satisfied charges of ₹1.06 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressM – 7/2 Street No.1 (Near Kakatiya Club) Kakatiyanagar Habshiguda, Hyderabad, Telangana, India – 500007
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Deepti Formulations Private Limited
The main business activity of Deepti Formulations is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Deepti Formulations Private Limited FY 2025 filings available
Deepti Formulations Private Limited reported revenue of ₹4.03 Cr (down 72% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Deepti Formulations Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 16% over five years, including a 72% fall in the latest year. EBITDA fell 123% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Deepti Formulations Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | -₹32.52 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹72.99 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Deepti Formulations Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -8.1% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -18.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Deepti Formulations are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Deepti Formulations Private Limited
Deepti Formulations Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Asclan Industries Private Limited | ₹4.05 Cr (FY 2025) | •••• | •••• | 5.0% | •••• | Lucknow, Uttar Pradesh, India |
| Haffkine Ajintha Pharmaceuticals Limited | ₹4.05 Cr (FY 2023) | •••• | •••• | 214.0% | •••• | Mumbai, Maharashtra, India |
| Anushakti Enterprise Private Limited | ₹4.05 Cr (FY 2025) | •••• | •••• | 1.0% | •••• | Mumbai, Maharashtra, India |
| Kolaz Biotech Private Limited | ₹4.05 Cr (FY 2025) | •••• | •••• | 0.0% | •••• | Ambala Cantt, Haryana, India |
| Dwarkesh Pharmaceutical Pvt Ltd | ₹4.04 Cr (FY 2025) | •••• | •••• | -10.0% | •••• | Ahmedabad, Gujarat, India |
| Deepti Formulations Private Limited this company | ₹4.03 Cr (FY 2025) | •••• | •••• | -72.0% | •••• | Hyderabad, Telangana, India |
| Shetye Pharma Enterprises Private Limited | ₹4.02 Cr (FY 2025) | •••• | •••• | 57.0% | •••• | Mapusa, Goa, India |
| Alves Healthcare Private Limited | ₹4.01 Cr (FY 2025) | •••• | •••• | -65.0% | •••• | Mumbai, Maharashtra, India |
| Arsun Healthcare Private Limited | ₹4.01 Cr (FY 2025) | •••• | •••• | -1.0% | •••• | Coimbatore, Tamil Nadu, India |
| Acpc Healthcare Private Limited | ₹4.01 Cr (FY 2024) | •••• | •••• | 128.0% | •••• | Mumbai, Maharashtra, India |
| Nikkon Lifescience Private Limited | ₹4.01 Cr (FY 2025) | •••• | •••• | 15.0% | •••• | Bangalore, Karnataka, India |
Peers are the five companies nearest above and the five nearest below Deepti Formulations by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Deepti Formulations Private Limited
Deepti Formulations Private Limited is audited by Niranjan & Narayan Chartered Accountants for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Niranjan & Narayan Chartered Accountants | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Deepti Formulations Private Limited
Deepti Formulations has 3 current directors and 4 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ashwini Chadda | Whole-Time Director | 11 Oct 2003 | 23 Years 0 Months | Current |
| Dhruv Chadda Also directs: Espi Industries and Chemicals Pvt Ltd | Director | 18 Dec 2020 | 5 Years 9 Months | Current |
| Deepti Chadda Also directs: Dreamcatchers Design LLP, Starpapaya Play LLP | Director | 01 Sep 2023 | 3 Years 1 Months | Current |
Ownership and Shareholding of Deepti Formulations Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Deepti Formulations Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Apr 2001 | Andhra Bank | ₹25 Lakh | Open |
| 28 Apr 1999 | Andhra Bank | ₹21.2 Lakh | Open |
| 20 Nov 1998 | Andhra Bank | ₹7.5 Lakh | Open |
| 14 Sep 1994 | Andhra Bank | ₹1.25 Lakh | Open |
| 28 Mar 1994 | Andhra Bank | ₹11.3 Lakh | Open |
Total charge records: 10 View all charges
MSME Payment Delays by Deepti Formulations Private Limited
Deepti Formulations Private Limited has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 6 overdue payments to 4 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (4 of 4)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| an individual supplier | •••• | •••• | •••• |
| Regal Paper and Packaging India Private Limited | •••• | •••• | •••• |
| Alutop | •••• | •••• | •••• |
| Sun Life Sciences | •••• | •••• | •••• |
Full MSME payment history
Every supplier, amount and due date from all 1 MSME Form 1 returns is in the company report.
- Every reported supplier due
- Amounts and due dates
- Reasons given in each return
- Period-by-period history
Verified entity values are shown only after access is granted.
Individuals and sole proprietors among the suppliers are not named. Amounts, due dates and filing dates are in the company report.
Employees and EPFO Compliance at Deepti Formulations Private Limited
Deepti Formulations Private Limited has a workforce of 36 employees as of Sep 26, 2025.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
CIN History of Deepti Formulations Private Limited
Deepti Formulations has one previous CIN (Corporate Identification Number): U24231AP1990PTC012122. The current CIN is U24231TG1990PTC012122, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24231TG1990PTC012122 | Current |
| U24231AP1990PTC012122 | Previous |
Recent Activity on Deepti Formulations Private Limited
Deepti Formulations Private Limited has 7 board changes on record since 2003: 3 appointments and 4 cessations. The latest: Deepti Chadda ceased to be Additional Director on 03 Sep 2024.
15 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Deepti Formulations Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Deepti Formulations Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Deepti Formulations Private Limited
Deepti Formulations has 2 GST registrations: 1 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAACD7145G1ZS | Telangana | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Deepti Formulations Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Deepti Formulations Private Limited
Deepti Formulations is an active private limited company based in Hyderabad, Telangana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 24 December 1990 (36+ years old) and is registered under CIN U24231TG1990PTC012122.
Deepti Formulations reported revenue of ₹4.03 Cr for FY 2025 (down 72% YoY).
Deepti Formulations has 3 current directors:
- Ashwini Chadda - Whole-Time Director
- Dhruv Chadda - Director
- Deepti Chadda - Director
Deepti Formulations reported a net loss of ₹72.99 Lakh (net margin -18.1%) and EBITDA of -₹32.52 Lakh (EBITDA margin -8.1%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Deepti Formulations is -22% over three years and -16% over five years. In the latest year (FY 2025) revenue fell 72%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Deepti Formulations is 36AAACD7145G1ZS, registered in Telangana. The company has 2 GST registrations in all, of which 1 is active and 1 is cancelled or inactive.
The CIN (Corporate Identification Number) of Deepti Formulations is U24231TG1990PTC012122. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Deepti Formulations was incorporated on 24 December 1990, making it 36+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Deepti Formulations by revenue are Asclan Industries Private Limited, Haffkine Ajintha Pharmaceuticals Limited, Anushakti Enterprise Private Limited, Kolaz Biotech Private Limited, Dwarkesh Pharmaceutical Pvt Ltd and 5 more, all in the Pharma industry (Formulations).
Deepti Chadda ceased to be Additional Director on 03 Sep 2024. Deepti Chadda was appointed as Director on 01 Sep 2023. Sastry Narasimha Josyula ceased to be Director on 05 Nov 2022. Deepti Formulations has 7 board changes on record in total.
Deepti Formulations has 1 MSME Form 1 return on record for the period ending Mar 2019, listing 6 overdue payments to 4 micro and small suppliers. The latest return was filed on 08 Jun 2019.
The registered office of Deepti Formulations is at M – 72 Street No.1 Near Kakatiya Club Kakatiyanagar Habshiguda, Hyderabad, Telangana, India – 500007.